Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What Makes Semaglutide Different Uses a single hormone pathway (GLP-1) to support appetite control Often a great option for patients who prefer a more gradual approach Well-studied with a long track record in metabolic care What Makes Tirzepatide Different Activates two hormone pathways (GLP-1 and GIP) for broader metabolic support May provide stronger appetite suppression for some patients Often considered for patients who need additional metabolic support or have experienced plateaus What Clinical Trials Show GLP-1s Can Do The Proof in the Data Semaglutide By week 68, 86.4% lost at least 5%, 69.1% lost at least 10%, and 50.5% lost at least 15%
Its a GLP-1 receptor agonist medication
That gradual increase is what keeps side effects manageable early on
If you cant keep fluids down for more than 24 hours, or you notice any of these symptoms, contact your healthcare team
US$ 26.70
US$ 22.80
US$ 22.70
